EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD36-mediated endocytosis of proteolysis-targeting chimeras

Zhengyu Wang, Bo-Syong Pan, Rajesh Kumar Manne, Jungang Chen, Dongwen Lv, Minmin Wang, Phuc Tran, Tsigereda Weldemichael, Wei Yan, Hongfei Zhou, Gloria M Martinez, Jingwei Shao und 6 weitere

Cell · 2025-06 · 188 (12) · 3219-3237.e18

DOI: 10.1016/j.cell.2025.03.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-06. Verfasst von Zhengyu Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Depart…. Hauptthemen laut MEDLINE: Endocytosis, CD36 Antigens. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Cancer Prevention and Research Institute of Texas, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Passive diffusion does not explain why many drugs are too large and/or too polar for rule-breaking membrane penetration, such as proteolysis-targeting chimeras (PROTACs, generally of a molecular weight > 800 Da). Here, using biotinylated chemical-probe-based target fishing and genetic knockdown/knockin approaches, we discovered that the membrane cluster of differentiation 36 (CD36) binds to and facilitates the uptake and efficacy of diverse PROTACs (e.g., SIM1-Me, MZ1, and clinical ARV-110) and large and/or polar small-molecule drugs (e.g., rapalink-1, rapamycin, navitoclax, birinapant, tubacin, and doxorubicin) via the CD36-mediated early endosome antigen 1 (EEA1)/Ras-related protein 5A (Rab5) endosomal cascade in vitro and/or in vivo. We then devised a novel chemical endocytic medicinal chemistry strategy to improve binding of PROTACs to CD36 using structural modifications via the prodrug approach, markedly enhancing PROTAC anti-tumor efficacy through spontaneously augmenting permeability and solubility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocytosisCD36 AntigensProteolysisHumansAnimalsMiceEndosomesCell Line, TumorAntineoplastic AgentsProdrugs

Stichwörter der Autor:innen

ADMECD36ERO5 and BRO5 moleculesPROTACcellular uptakechemical endocytic medicinal chemistryendocytosispolar and large moleculesprecision medicineproximity-induced molecules

Substanzen

CD36 AntigensAntineoplastic AgentsProdrugs

Autor:innen und Institutionen

  • Department of Pharmacology, The Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Department of Pharmaceutical Science, College of Pharmacy, University of Ark…
  • Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA; Department of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA.
  • Department of Pathology and Winthrop P. Rockefeller Cancer Institute, School of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Department of Biochemistry and Structural Biology, Center for Innovative Drug Discovery, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Pharmacology, The Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
  • Department of Pharmaceutical Science, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Förderung

  • NCI NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Cancer Institute
  • University of Texas at San Antonio
  • Duke University
  • National Institutes of Health
  • Wake Forest School of Medicine
  • Arkansas Biosciences Institute

Zitieren

APA

Wang, Z., Pan, B. S., Manne, R. K., Chen, J., Lv, D., Wang, M., Tran, P., Weldemichael, T., Yan, W., Zhou, H., Martinez, G. M., Shao, J., Hsu, C. C., Hromas, R., Zhou, D., Qin, Z., Lin, H. K., & Li, H. Y. (2025). CD36-mediated endocytosis of proteolysis-targeting chimeras. Cell, 188(12), 3219-3237.e18. https://doi.org/10.1016/j.cell.2025.03.036

Vancouver

Wang Z, Pan BS, Manne RK, Chen J, Lv D, Wang M, et al. CD36-mediated endocytosis of proteolysis-targeting chimeras. Cell. 2025;188(12):3219-3237.e18. doi:10.1016/j.cell.2025.03.036

BibTeX
@article{Wang2025,
  author = {Wang, Zhengyu and Pan, Bo-Syong and Manne, Rajesh Kumar and Chen, Jungang and Lv, Dongwen and Wang, Minmin and Tran, Phuc and Weldemichael, Tsigereda and Yan, Wei and Zhou, Hongfei and Martinez, Gloria M and Shao, Jingwei and Hsu, Che-Chia and Hromas, Robert and Zhou, Daohong and Qin, Zhiqiang and Lin, Hui-Kuan and Li, Hong-Yu},
  title = {CD36-mediated endocytosis of proteolysis-targeting chimeras},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {12},
  pages = {3219--3237.e18},
  doi = {10.1016/j.cell.2025.03.036}
}
Kostenlos starten →